Skip to main content
logo
ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
8.81
+0.18 (2.09%)
At close: Oct 28, 2026, 4:00 PM EDT
8.84
+0.03 (0.34%)
Pre-market: Oct 29, 2026, 6:36 AM EDT

ImmunityBio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
9,3371,9501,8693,3522,0762,419
Market Cap Growth
283.79%4.33%-44.23%61.49%-14.18%-
Enterprise Value
10,2082,5522,7593,8822,6762,681
Last Close Price
8.811.982.565.025.076.08

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
56.3217.22126.775388.888648.472589.53
PB Ratio
--3.90-3.83-5.72-4.61-9.92

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
61.5722.53187.096241.2011149.272870.55

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.17-1.69-1.62-1.51-1.61-2.66
Net Debt / Equity Ratio
-0.83-1.20-1.31-1.05-1.37-1.35
Net Debt / EBITDA Ratio
-3.70-2.50-1.96-1.80-1.86-1.09
Net Debt / FCF Ratio
-3.02-1.95-1.61-1.55-1.48-1.07
Asset Turnover
0.320.260.030.000.000.00
Inventory Turnover
0.260.16----
Quick Ratio
5.364.622.784.630.220.86
Current Ratio
5.725.103.365.050.280.91
Return on Assets (ROA)
-30.54%-36.17%-48.48%-52.11%-52.73%-57.48%
Return on Capital Employed (ROCE)
-45.60%-58.20%-104.90%-81.00%253.20%-317.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-11.22%-18.02%-22.13%-17.40%-20.07%-14.34%
FCF Yield
-3.09%-15.83%-21.30%-11.85%-20.03%-12.73%
Buyback Yield / Dilution
-26.61%-31.33%-37.71%-27.19%-2.74%-3.23%
SEC Filings: 10-K · 10-Q